Chapters
Transcript
Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): Post-hoc analysis of CheckMate 214.
Related Presenters
Wenxin Xu, MD
Medical Oncology
View full Profile
Related Videos
Kidney Cancer Conference Highlights from ASCO GU 2025
Prostate Cancer Conference Highlights from ASCO GU 2025
Bladder Cancer Conference Highlights from ASCO GU 2025
Toni Choueiri, MD discusses a novel HIF-2alpha inhibitor called casdatifan
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account